Retroviral gene transfer of epidermal growth factor receptor into HL60 cells results in a partial block of retinoic acid-induced granulocytic differentiation.
HL60 cells are devoid of endogenous epidermal growth factor receptor (EGFR). They respond to retinoic acid and undergo terminal granulocytic differentiation. EGFR complementary DNA was introduced into HL60 cells by retroviral gene transfer. Scatchard plot showed that the binding characteristics are identical to those of A431 cells. HL60-EGFR cells were estimated to express 34,000 EGFR/cell (Kd = 5 nM). The tyrosine phosphorylation upon ligand binding is the first step of signal transduction. The dominant phosphotyrosyl proteins in epidermal growth factor-stimulated HL60-EGFR cells include a 170 kDa protein (EGFR itself), and 125 and 53 kDa proteins. The EGFR signal results in the induction of 92 kDa gelatinase/matrix metalloproteinase in HL60-EGFR cells, thereby providing evidence of the function of the exogenous EGFR and a semiquantitative measure of the EGFR signal. These HL60-EGFR cells offer a unique opportunity to examine the potentially important role of EGFR (c-erbB) in maintaining homeostasis between self-renewal and differentiation. c-erbB has been shown to play a physiological role in the self-renewal of the very early avian stem cells which do express EGFR. The v-erbB (double truncated EGFR) has been shown to cause avian erythroblastosis. We found that these HL60-EGFR cells responded to retinoic acid differently from the HL60-control cells. A partial block of only 45% granulocytic differentiation and concomitant proliferation was noted, consistent with a shift of balance between self-renewal and differentiation toward the former.
Chen
L L
LL
Division of Hematology and Oncology, University of Connecticut Health Center, Farmington 06030.
Gansbacher
B
B
Gilboa
E
E
Taetle
R
R
Oval
J
J
Hibbs
M S
MS
Huang
C K
CK
Clawson
M L
ML
Bilgrami
S
S
Schlessinger
J
J
D002454:Cell Differentiation / Q000187:drug effects; D066246:ErbB Receptors / Q000235:genetics*; D018014:Gene Transfer Techniques; D006098:Granulocytes / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D012190:Retroviridae / Q000235:genetics*; D015398:Signal Transduction / Q000235:genetics*; D014212:Tretinoin / Q000037:antagonists & inhibitors*; D014407:Tumor Cells, Cultured
D014212:Tretinoin; D066246:ErbB Receptors